In 1974, President Nixon signed the Narcotic Addiction Treatment Act, which gave statutory authority to the regulations governing the provision of methadone for the treatment of opioid use disorder (OUD) in the US. The original name for the bill was revealing: the Methadone Diversion Control Act. These regulations that were meant to restrict dispensation on methadone have undergone only modest revision over the ensuing decades even in the midst of a current overdose epidemic.1 In the US, methadone for OUD can only be provisioned at federally certified opioid treatment programs (OTPs). Patients receiving methadone must present to an OTP for initial evaluation and then return 6 days a week for medication dispensing for at least the first 90 days of treatment (the latter requirement was relaxed during the coronavirus disease 2019 [COVID-19] pandemic). At least weekly dispensing is required through the first year and only if patients meet specific requirements. The federal law (42 CRF 8) also mandates patients regularly engage with counseling services; state and municipal governments then layer on additional requirements.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Joudrey PJ, Edelman EJ, Wang EA. Methadone for Opioid Use Disorder—Decades of Effectiveness but Still Miles Away in the US. JAMA Psychiatry. 2020;77(11):1105–1106. doi:10.1001/jamapsychiatry.2020.1511
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: